BioStem Technologies, Inc.(BSEM US)
$1.05-0.2519.23%
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.7 | 301.8 | 47.5 | -18.9 | |||||||||||||||
| -Cost of Revenue | 1.3 | 13.7 | 3.3 | 5.3 | |||||||||||||||
| Gross Profit | 15.4 | 287.9 | 44.2 | -24.2 | |||||||||||||||
| -Operating Expenses | 23.2 | 256.7 | 44.9 | -9.4 | |||||||||||||||
| +Selling, General & Admin | 22.6 | 254.7 | 37.8 | -15.9 | |||||||||||||||
| +General And Administrative Expenses | 10.6 | 18.7 | - | 11.4 | |||||||||||||||
| +Selling And Marketing Expenses | 12.0 | 236.1 | - | 40.9 | |||||||||||||||
| +Research and Development | 0.3 | 1.9 | 7.1 | 6.5 | |||||||||||||||
| +Other Operating Expenses | 0.2 | - | - | -0.1 | |||||||||||||||
| Operating Income | -7.8 | 31.2 | -0.7 | -14.8 | |||||||||||||||
| +Non Operating Income | -1.4 | -1.2 | 0.7 | 0.8 | |||||||||||||||
| +Interest Income, Net | -0.7 | -0.6 | 0.4 | 0.4 | |||||||||||||||
| +Interest Income | - | - | 0.4 | 0.4 | |||||||||||||||
| -Interest Expense | 0.7 | 0.6 | - | - | |||||||||||||||
| +Other Non-Op Income | -0.7 | -0.6 | 0.3 | 0.3 | |||||||||||||||
| Pretax Income | -8.5 | 30.6 | -0.4 | -14.5 | |||||||||||||||
| -Income Tax Expense | - | -1.3 | 6.2 | 5.4 | |||||||||||||||
| Income from Cont Ops | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||||||
| +Discounted operations | - | - | - | - | |||||||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||||||
| Income Incl. MI | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Minority Interests | - | - | - | -0.0 | |||||||||||||||
| Net Income, GAAP | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||||||
| Net Income Avail To Common | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| Weighted Average Shs Out | 13,707,081 | 16,368,428 | 16,728,783 | 67,038,519 | |||||||||||||||
| EPS | -0.6 | 2.0 | -0.4 | -1.2 | |||||||||||||||
| Weighted Average Shs Out Dil | 13,707,077 | 21,698,384 | 16,728,783 | 81,561,823 | |||||||||||||||
| EPS Diluted | -0.6 | 1.5 | -0.4 | -1.2 | |||||||||||||||
| Millions USD (ex. Per Share) | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.7 | 301.8 | 47.5 | -18.9 | |||||||||||||||
| -Cost of Revenue | 1.3 | 13.7 | 3.3 | 5.3 | |||||||||||||||
| Gross Profit | 15.4 | 287.9 | 44.2 | -24.2 | |||||||||||||||
| -Operating Expenses | 23.2 | 256.7 | 44.9 | -9.4 | |||||||||||||||
| +Selling, General & Admin | 22.6 | 254.7 | 37.8 | -15.9 | |||||||||||||||
| +General And Administrative Expenses | 10.6 | 18.7 | - | 11.4 | |||||||||||||||
| +Selling And Marketing Expenses | 12.0 | 236.1 | - | 40.9 | |||||||||||||||
| +Research and Development | 0.3 | 1.9 | 7.1 | 6.5 | |||||||||||||||
| +Other Operating Expenses | 0.2 | - | - | -0.1 | |||||||||||||||
| Operating Income | -7.8 | 31.2 | -0.7 | -14.8 | |||||||||||||||
| +Non Operating Income | -1.4 | -1.2 | 0.7 | 0.8 | |||||||||||||||
| +Interest Income, Net | -0.7 | -0.6 | 0.4 | 0.4 | |||||||||||||||
| +Interest Income | - | - | 0.4 | 0.4 | |||||||||||||||
| -Interest Expense | 0.7 | 0.6 | - | - | |||||||||||||||
| +Other Non-Op Income | -0.7 | -0.6 | 0.3 | 0.3 | |||||||||||||||
| Pretax Income | -8.5 | 30.6 | -0.4 | -14.5 | |||||||||||||||
| -Income Tax Expense | - | -1.3 | 6.2 | 5.4 | |||||||||||||||
| Income from Cont Ops | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||||||
| +Discounted operations | - | - | - | - | |||||||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||||||
| Income Incl. MI | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Minority Interests | - | - | - | -0.0 | |||||||||||||||
| Net Income, GAAP | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||||||
| Net Income Avail To Common | -8.5 | 31.9 | -6.6 | -19.9 | |||||||||||||||
| Weighted Average Shs Out | 13,707,081 | 16,368,428 | 16,728,783 | 67,038,519 | |||||||||||||||
| EPS | -0.6 | 2.0 | -0.4 | -1.2 | |||||||||||||||
| Weighted Average Shs Out Dil | 13,707,077 | 21,698,384 | 16,728,783 | 81,561,823 | |||||||||||||||
| EPS Diluted | -0.6 | 1.5 | -0.4 | -1.2 | |||||||||||||||